• Case Report
• Open Access
• Fischer Mahir, PhD

Hepatitis C virus (HCV) infection is presently one among the most causes of liver disease and malignant hepatoma (HCC) at a worldwide level. Recently, a brand new generation of direct-acting antiviral agents (DAAs) has entered the HCV treatment landscape, providing imposingly high rates of sustained medicine response (SVR), associate degreed is anticipated to steer to an ultimate decrease in HCV-related liver disease, liver transplantation and mortality. However, throughout the primary years of their use, many studies reportable a potential correlation between DAA treatment associate degreed an redoubled risk of HCC.

• Research Article
• Open Access
• Yuien-Chun, PhD

The aim of the study was to assess the effectivity and safety of tofacitinib and its impact on quality of life in patients with moderate-to-severe colitis. Methods we have a tendency to conducted a scientific review and meta-analysis of randomised controlled trials scrutiny tofacitinib with placebo or any active comparator.

• Mini Review
• Open Access
• Wang Wei

Air embolism isn’t diagnosed and is usually fatal. The identification is usually not created in a very timely manner given the speedy and severe clinical deterioration that always develops, ofttimes resulting in pathology. several patients ar solely diagnosed post-mortem.